Clinical Study
Sarcoidosis Treatment with Antifungal Medication: A Follow-Up
Table 2
Clinical parameters at initiation of treatment, after 6 months of treatment, and at remission. Mean/SEM.
| Treatment | Corticosteroid | Antifungal | AF + C |
| | 21 | 20 | 27 |
X-ray score | | | | Before | 1.7/0.1 | 1.9/0.2 | 2.2/0.2 | 6 months | 1.1/0.1 | 0.6/0.2 | 0.8/0.1 | Remission | 0.6/0.2 | 0.1/0.1 | 0.3/0.1 | CTO nmol/h/mL | | | | Before | 843/86 | 454/70 | 632/108 | 6 months | 260/44 | 372/149 | 184/52 | Remission | 342/57 | 271/66 | 178/37 | ACE µKat/L | | | | Before | 0.44/0.05 | 0.44/0.04 | 0.41/0.03 | 6 months | 0.20/0.02 | 0.38/0.04 | 0.26/0.03 | Remission | 0.24/0.03 | 0.34/0.03 | 0.24/0.02 | DLco % pred. | | | | Before | 80.5/3.6 | 92.3/3.3 | 89.6/3.5 | 6 months | 79.0/5.5 | 92.9/3.7 | 91.1/4.7 | Remission | 90.8/3.6 | 95.7/3.5 | 93.4/3.6 |
|
|